Melatonin receptor — Drug Target
All drugs that target Melatonin receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- Morning Group · Rush University Medical Center · Melatonin receptor agonist · Sleep disorder
Morning Group is a medication that helps regulate sleep-wake cycles.
Phase 3 pipeline (1)
- pediatric, prolonged released melatonin · University Hospital, Strasbourg, France · Melatonin receptor agonist · Sleep disorders
Melatonin is a hormone that regulates sleep-wake cycles, and prolonged release formulations aim to maintain therapeutic levels throughout the night.